1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid TumorsCytopenia, Hemic and Lymphatic Diseases, blood platelet disease, hematologic disorder, neoplasm, thrombocytopeniaNot yet recruitingNot applicable2025-09-22NCT07185893